My best guess in the short term (excluding technological surprises) would have to be MDA Phase II and/or mandate expansion. I wouldn't be surprised if, given both we could double our pps, short-mid term... Plus there is always the possibility of a Pharma deal which, depending on specifics, I believe could do the same. I remain optimistic though the scale of any dilution would put a damper on things.
News 
Market Data 
Discover 
AI
